BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34311708)

  • 1. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
    Oye-Somefun A; Kuk JL; Ardern CI
    BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Metabolic Syndrome and Mortality: Prospective Cohort Study.
    Li W; Chen D; Peng Y; Lu Z; Kwan MP; Tse LA
    JMIR Public Health Surveill; 2023 Sep; 9():e44073. PubMed ID: 37669100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
    Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
    Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Nutritional Biomarkers and All-Cause and Cause-Specific Mortality in U.S. Adults with Metabolic Syndrome: The Results from National Health and Nutrition Examination Survey 2001-2006.
    Peng X; Zhu J; Lynn HS; Zhang X
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
    Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
    Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes.
    Sidorenkov O; Nilssen O; Grjibovski AM
    BMC Public Health; 2010 Sep; 10():582. PubMed ID: 20920226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum high density lipoprotein is associated with the greatest risk of metabolic syndrome among U.S. adults.
    Castaneda G; Bhuket T; Liu B; Wong RJ
    Diabetes Metab Syndr; 2018; 12(1):5-8. PubMed ID: 28826579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
    Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
    JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease.
    Ndrepepa G; Holdenrieder S; Cassese S; Fusaro M; Xhepa E; Laugwitz KL; Schunkert H; Kastrati A
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):64-70. PubMed ID: 29126670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal-related biomarkers and long-term mortality in the US subjects with different coronary risks.
    Wu CK; Chang MH; Lin JW; Caffrey JL; Lin YS
    Atherosclerosis; 2011 May; 216(1):226-36. PubMed ID: 21371709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
    Esteghamati A; Hafezi-Nejad N; Zandieh A; Sheikhbahaei S; Ebadi M; Nakhjavani M
    J Cardiol; 2014 Oct; 64(4):290-6. PubMed ID: 24631466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.